Zomato gets relief as GST authorities drop Rs 5.9 crore tax demand

Food and grocery delivery giant Zomato has received relief from tax authorities as a demand for Rs 5.9 crore in unpaid Goods and Services Tax (GST) has been dropped.

Also ReadPepsiCo records double-digit growth in India

In a regulatory filing, Zomato stated that it had received a favorable order from the Commissioner (Appeals) in Gurugram, overturning an earlier demand order passed by the Additional Commissioner, Central Goods and Services Tax, Gurugram. The tax demand was initially raised for the period from July 2017 to March 2021.

The company had contested the demand since April last year, maintaining that it saw no merit in the claim. Along with penalties, the total demand had amounted to Rs 11.82 crore. The tax assessment was based on export services provided by Zomato to its foreign subsidiaries.

Also Read Could Zomato share price fall 44%? Macquarie say Yes. Here’s Why… Analysts bullish on Zomato despite share dip Zomato Q3 Results: Profit dips significantly to Rs 59 crore on continued store expansion, revenue up 64.39% YoY Zomato Share Price Today Highlights, 20 Jan, 2025: Zomato closes 7% lower post Q3 results

This is not the only tax-related challenge Zomato has faced. The company has received multiple GST notices from various authorities across the country. The largest of these is a Rs 803 crore GST demand, related to alleged unpaid taxes for the period from October 29, 2019, to March 31, 2022. Zomato is currently appealing against this claim.

Also ReadBudget underscores positive outlook on India rating: S&P

Despite these tax disputes, Zomato continues to expand its operations in the food and grocery delivery sector. The company has assured investors that it is addressing all compliance matters in accordance with legal requirements.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations